Orris

These are slides, we'll be including to the ppt:- 1. Title Slide & Introduction 2.Objectives 3.Guideline Development Working Groups. 4. Methods 5. Clinical Practice Guidelines:- 5.1 Defination & Diagnosis Of Asthma 5.2 Recognizing & Managing acute exacerbations 5.3 Principles of Long term Management in Asthma 5.4 Education and Prevention of Asthma 5.5 Risk Evaluation 6.Summary 7. Refrences 8.Ending Slide.. these are the topic in slides of ppt .. my topic is just 5.3 so give me answers accordingly to the given ppt for 5.3 sections .. provide me content for 5 to 8 slides just from the given pdf.. make a slide content in simple understandable .. make me ppt also so I use it as reference for a canva which I gonna make

Reading File
Reading File
Reading File
Running Command
Running Command
Running Command
Running Command
Writing File
Running Command
The PPT is ready. Here's a full breakdown of all 7 slides with the content pulled directly from your PDF:

πŸ“₯ Download Your PPT

Asthma LongTerm Management 5.3

Presentation Β· PPTX

Slide-by-Slide Content Summary

Slide 1 β€” Section Title Slide

"Principles of Long-Term Management in Asthma" with sub-topics listed (Pharmacologic Β· Step Therapy Β· Step-Down Β· Referral Β· Self-Management)

Slide 2 β€” Overview: 3 Components of Long-Term Management

Three pillars from Chapter 3:
ComponentDetails
πŸ’Š Pharmacologic ManagementICS, ICS-LABA, SABA (Key Q4)
🌿 Non-Pharmacologic StrategiesTrigger avoidance, prevention (Key Q 6,7,8)
πŸ“‹ Self-Management & EducationWritten Asthma Action Plan (Key Q5)
Key principle: Strong patient-family-provider partnership is essential.

Slide 3 β€” Pharmacological Management: 3 Drug Categories + Step Review

  • Controller (ICS, ICS-LABA) β€” reduce inflammation, prevent exacerbations
  • Reliever/Rescue (SABA) β€” all patients get this for acute symptoms
  • Add-on/Adjunct β€” biologics, LAMA for uncontrolled severe asthma
  • Review response at 1–3 months β†’ every 3–12 months; follow-up within 1 week post-exacerbation

Slide 4 β€” Step Therapy Table by Age Group

A colour-coded table showing Steps 1–5 for:
  • Children <6 years (pMDI + spacer, low-dose ICS)
  • Children 6–11 years (SMART option introduced at Step 3)
  • Adolescents 12–18 years β€” Track 1 (ICS-formoterol as-needed) vs Track 2 (low ICS + SABA)

Slide 5 β€” When & How to Step Down Treatment

When: β‰₯3 months good control + lung function stable + right timing (no infection, not pregnant) How (6 principles):
  1. Reduce ICS by 25–50% every 3 months
  2. Provide updated Written Asthma Action Plan
  3. Identify risk factors (recent ER visit, low FEV₁)
  4. Do NOT fully withdraw ICS
  5. Keep previous-dose meds available
  6. Monitor PEF + schedule follow-up

Slide 6 β€” Specialist Referral & Difficult-to-Treat Asthma

Refer when: diagnosis unclear, uncontrolled on Step 4, near-fatal attack, food allergy + asthma, treatment side-effects, growth delay Difficult asthma: First rule out poor inhaler technique (80%), poor adherence (75%), wrong diagnosis, comorbidities (GERD, obesity, OSA, rhinosinusitis)

Slide 7 β€” Self-Management & FeNO Adjunct

  • WAAP (Written Asthma Action Plan) β€” must be updated at every visit
  • Self-monitoring β€” symptoms and/or PEF
  • Regular physician review β€” control, treatment, inhaler skills
  • FeNO β€” weak recommendation; adjunct only; reduces exacerbation risk (RR 0.73, 23 RCTs)
The PPT uses a Navy + Teal + White colour scheme that works great as a Canva reference. All content is sourced word-for-word from your PDF (Chapter 3, Sections 11–15).
This is a shared conversation. Sign in to Orris to start your own chat.